Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial
van der Ree, Meike H, de Vree, J Marleen, Stelma, Femke, Willemse, Sophie, van der Valk, Marc, Rietdijk, Svend, Molenkamp, Richard, Schinkel, Janke, van Nuenen, Ad C, Beuers, Ulrich, Hadi, Salah, HarbVolume:
389
Langue:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(16)31715-9
Date:
February, 2017
Fichier:
PDF, 1.03 MB
english, 2017
File converter
Plus de résultats de recherche
More benefits 
